News

On May 24 the Netherlands Proteomics PLatfrom gathered for its 20th anniversary meeting. It was a fantastic meeting with ~ 85 participants to which we contributed two talks. See here for the program https://www.netherlandsproteomicsplatform.nl/2022-spring-meeting/

It was an honour and great pleasure to speak at the joint German Proteomics Forum -European Proteomics Association meeting in Leipzig on phosphoproteomics for precision medicine. See here for the program full of great science : https://www.proteomic-forum.com/programme/scientific-programme

The next NPP meeting will be held on Tuesday 24 May 2022 in conference center ‘De Driehoek’ in Utrecht! Join us for an exciting program with contributions from proteomics labs all around the country. Also, there will be lots of opportunities to interact with friends and colleagues. The scientific program is here.

The Journal of Experimental & Clinical Cancer Research (JECCR) has congratulated Connie Jimenez on authoring one of the most-downloaded papers published in the journal during 2021 (‘High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer’). Since publishing, the article has been downloaded 3144 times. Go see the article

Our study published Feb. 25 in Nature Communications shows that phosphoproteomic profiling can discover novel targets for therapy for T-ALL and it can guide the design of treatment combination strategies when a single therapy is not sufficient. The analysis of active proteins gives us a more complete picture of the leukemia and allows for selection […]

Zhu T, Zhu Y, Xuan Y, Gao H, Cai X, Piersma SR, Pham TV, Schelfhorst T, Haas RRGD, Bijnsdorp IV, Sun R, Yue L, Ruan G, Zhang Q, Hu M, Zhou Y, Van Houdt WJ, Le Large TYS, Cloos J, Wojtuszkiewicz A, Koppers-Lalic D, Böttger F, Scheepbouwer C, Brakenhoff RH, van Leenders GJLH, Ijzermans JNM, […]

16 November 2021 15:45 Fine-tuning prediction of response and survival in acute myeloid leukemia PhD defence by D.G.J. Cucchi

This progress report 2018-2021 covers proteomics research of the OncoProteomics Laboratory (OPL) and collaborators, as well as proteomics activities performed in the context of our function as Proteomics Core Facility. It harbors information on our mass spectrometry infrastructure and proteomics expertise, output, academic activities and includes summaries of running core and collaborative projects.

After the first Annals of Internal Medicine paper describing the proteomics discovery and validation of stool protein for colorectal cancer screening, we now are proud to report the follow-up large scale validation in FIT samples using antibodies. again published in Annals of Internal Medicine. Bosch LJW, de Wit M, Pham TV, Coupé VMH, Hiemstra AC, […]

Alexia, Elena, and Merih and learned all about proteomics and performed an experiment on their own samples as well as some Dutch highlights.